{"id":12608,"date":"2024-12-13T10:22:14","date_gmt":"2024-12-13T10:22:14","guid":{"rendered":"https:\/\/www.pkf-attest.es\/?post_type=noticias&p=12608"},"modified":"2024-12-18T12:46:42","modified_gmt":"2024-12-18T12:46:42","slug":"informe-iberian-ma-sector-farmaceutico","status":"publish","type":"noticias","link":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/","title":{"rendered":"Iberian M&A Overview – Industria farmac\u00e9utica"},"content":{"rendered":"\n

Inversores estrat\u00e9gicos a la vanguardia de operaciones en el sector farma mundial<\/h2>\n\n\n\n

<\/p>\n\n\n\n

<\/div>\n\n\n\n

En el sector salud global, los inversores estrat\u00e9gicos se posicionan a la vanguardia de la actividad de acuerdos, con un enfoque claro en la adquisici\u00f3n tanto de capacidad como de innovaci\u00f3n. Durante el primer semestre de 2024, se observ\u00f3 una leve disminuci\u00f3n en la actividad global de fusiones y adquisiciones (M&A, por sus siglas en ingl\u00e9s) en comparaci\u00f3n con la segunda mitad de 2023. Este comportamiento refleja un entorno prudente de M&A, en el que los inversores prefieren esperar posibles recortes en las tasas de inter\u00e9s antes de comprometerse con transacciones significativas.<\/p>\n\n\n\n

A pesar de esta cautela, los m\u00faltiplos de negociaci\u00f3n de EBITDA experimentaron un aumento respecto al semestre anterior, impulsados por tendencias relevantes en la industria. Este fen\u00f3meno destaca la resiliencia del sector y su capacidad para adaptarse a los desaf\u00edos macroecon\u00f3micos.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\n
\n

Descubre la actividad global de fusiones y adquisiciones<\/strong> del sector sanitario en Iberia<\/strong><\/h3>\n\n\n\n
<\/div>\n\n\n\n

Descarga nuestro informe exclusivo y gratuito \u00abIberian M&A Overview\u00bb, elaborado por los expertos en M&A o fusiones y adquisiciones de PKF Attest. <\/p>\n\n\n\n

<\/div>\n\n\n\n

Accede a datos y tendencias esenciales del mercado en 2024. <\/p>\n<\/div><\/div>\n\n\n\n

\n
\"m&A<\/figure><\/div>\n\n\n
\n
Descargar informe<\/a><\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n

Din\u00e1mica en la regi\u00f3n ib\u00e9rica<\/strong><\/h2>\n\n\n\n


En el sector farmac\u00e9utico ib\u00e9rico, se registr\u00f3 una actividad destacada por parte de fondos de capital privado (Private Equity). Una de las operaciones m\u00e1s relevantes del ejercicio fiscal 2024 fue la adquisici\u00f3n de una participaci\u00f3n minoritaria en Grifols por parte de Flat Footed, una entidad estadounidense de gesti\u00f3n de inversiones. Este acuerdo, valorado en aproximadamente 111 millones de euros, subraya el atractivo continuo de los activos sanitarios en la regi\u00f3n para los inversores internacionales.<\/p>\n\n\n\n

En t\u00e9rminos de m\u00faltiplos de valoraci\u00f3n EV\/EBITDA, el sector sanitario alcanz\u00f3 un promedio de 12x, mientras que el sector veterinario se situ\u00f3 en 10,5x para el ejercicio fiscal 2024, reflejando diferencias en las din\u00e1micas de mercado y las expectativas de crecimiento dentro de ambos segmentos.<\/p>\n\n\n\n

Desc\u00e1rgate el Iberian M&A Overview sobre el sector farmac\u00e9utico<\/span>.<\/p>\n","protected":false},"featured_media":12612,"template":"noticias-corporativa-single-post.php","categories":[],"tags":[170,160,169],"novedades_corporativa":[],"acf":[],"yoast_head":"\nIberian M&A Overview - Industria farmac\u00e9utica | Informe completo<\/title>\n<meta name=\"description\" content=\"Descarga el informe completo. Inversores estrat\u00e9gicos lideran el sector sanitario global, en un entorno prudente en 2024. Destaca Private Equity.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Iberian M&A Overview - Industria farmac\u00e9utica\" \/>\n<meta property=\"og:description\" content=\"Descarga el informe completo. Inversores estrat\u00e9gicos lideran el sector sanitario global, en un entorno prudente en 2024. Destaca Private Equity.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-18T12:46:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/\",\"url\":\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/\",\"name\":\"Iberian M&A Overview - Industria farmac\u00e9utica | Informe completo\",\"isPartOf\":{\"@id\":\"https:\/\/www.pkf-attest.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg\",\"datePublished\":\"2024-12-13T10:22:14+00:00\",\"dateModified\":\"2024-12-18T12:46:42+00:00\",\"description\":\"Descarga el informe completo. Inversores estrat\u00e9gicos lideran el sector sanitario global, en un entorno prudente en 2024. Destaca Private Equity.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#primaryimage\",\"url\":\"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg\",\"contentUrl\":\"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg\",\"width\":2560,\"height\":960,\"caption\":\"M&A overview\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\/\/www.pkf-attest.es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Iberian M&A Overview – Industria farmac\u00e9utica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.pkf-attest.es\/#website\",\"url\":\"https:\/\/www.pkf-attest.es\/\",\"name\":\"PKF Attest\",\"description\":\"PKF Attest\",\"publisher\":{\"@id\":\"https:\/\/www.pkf-attest.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.pkf-attest.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.pkf-attest.es\/#organization\",\"name\":\"PKF-Attest\",\"url\":\"https:\/\/www.pkf-attest.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.pkf-attest.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2023\/12\/Logotipo_PKF-Attest-675x675-1.jpg\",\"contentUrl\":\"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2023\/12\/Logotipo_PKF-Attest-675x675-1.jpg\",\"width\":675,\"height\":675,\"caption\":\"PKF-Attest\"},\"image\":{\"@id\":\"https:\/\/www.pkf-attest.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/1078028\/admin\/dashboard\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Iberian M&A Overview - Industria farmac\u00e9utica | Informe completo","description":"Descarga el informe completo. Inversores estrat\u00e9gicos lideran el sector sanitario global, en un entorno prudente en 2024. Destaca Private Equity.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/","og_locale":"es_ES","og_type":"article","og_title":"Iberian M&A Overview - Industria farmac\u00e9utica","og_description":"Descarga el informe completo. Inversores estrat\u00e9gicos lideran el sector sanitario global, en un entorno prudente en 2024. Destaca Private Equity.","og_url":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/","article_modified_time":"2024-12-18T12:46:42+00:00","og_image":[{"width":2560,"height":960,"url":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/","url":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/","name":"Iberian M&A Overview - Industria farmac\u00e9utica | Informe completo","isPartOf":{"@id":"https:\/\/www.pkf-attest.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#primaryimage"},"image":{"@id":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg","datePublished":"2024-12-13T10:22:14+00:00","dateModified":"2024-12-18T12:46:42+00:00","description":"Descarga el informe completo. Inversores estrat\u00e9gicos lideran el sector sanitario global, en un entorno prudente en 2024. Destaca Private Equity.","breadcrumb":{"@id":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#primaryimage","url":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg","contentUrl":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg","width":2560,"height":960,"caption":"M&A overview"},{"@type":"BreadcrumbList","@id":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.pkf-attest.es\/"},{"@type":"ListItem","position":2,"name":"Iberian M&A Overview – Industria farmac\u00e9utica"}]},{"@type":"WebSite","@id":"https:\/\/www.pkf-attest.es\/#website","url":"https:\/\/www.pkf-attest.es\/","name":"PKF Attest","description":"PKF Attest","publisher":{"@id":"https:\/\/www.pkf-attest.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pkf-attest.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.pkf-attest.es\/#organization","name":"PKF-Attest","url":"https:\/\/www.pkf-attest.es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pkf-attest.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2023\/12\/Logotipo_PKF-Attest-675x675-1.jpg","contentUrl":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2023\/12\/Logotipo_PKF-Attest-675x675-1.jpg","width":675,"height":675,"caption":"PKF-Attest"},"image":{"@id":"https:\/\/www.pkf-attest.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/1078028\/admin\/dashboard\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.pkf-attest.es\/wp-json\/wp\/v2\/noticias\/12608"}],"collection":[{"href":"https:\/\/www.pkf-attest.es\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.pkf-attest.es\/wp-json\/wp\/v2\/types\/noticias"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pkf-attest.es\/wp-json\/wp\/v2\/media\/12612"}],"wp:attachment":[{"href":"https:\/\/www.pkf-attest.es\/wp-json\/wp\/v2\/media?parent=12608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pkf-attest.es\/wp-json\/wp\/v2\/categories?post=12608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pkf-attest.es\/wp-json\/wp\/v2\/tags?post=12608"},{"taxonomy":"novedades_corporativa","embeddable":true,"href":"https:\/\/www.pkf-attest.es\/wp-json\/wp\/v2\/novedades_corporativa?post=12608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}